Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Point-of-Care Immunoasay for Diagnosis of Inhalational Anthrax

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves the development of a point-of-care immunoassay designed for the early diagnosis of inhalational anthrax infections. Currently held by InBios International Inc under contract HHSO100201700029C, the project is valued at 3,957,468 dollars and utilizes a cost plus fixed fee pricing structure. The initiative is managed by the Department of Health and Human Services through Barda. The current agreement is projected to end on August 31, 2026, and is identified as a high-confidence full recompete opportunity. The upcoming solicitation is expected to be conducted under full and open competition, with the primary focus remaining on the advancement of diagnostic assays for biological threats.

General Info

InBios develops anthrax diagnostic assays for HHS Barda through August 31, 2026.

Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

WA, 981043829, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedMar 3

pre-forecast

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Contacts1 person available

OfficeN/A

Organization / AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Office AddressN/A

Contacts

Thomas P. HastingsContracting Officer

contact@example.gov

+1 (555) 000-0000

Full Description

Show more

Predicted recompete opportunity based on federal award data.
Current Contract: HHSO100201700029C Incumbent: INBIOS INTERNATIONAL INC Contract Value: $3,957,468 Potential End Date: 2026-08-31T00:00:00.000Z Competition: FULL AND OPEN COMPETITION Pricing: COST PLUS FIXED FEE Classification: full-recompete (Confidence: high - 90/100)
InBios is seeking funding to develop and assay for the early diagnosis os Anthrax inhalational infection.

Similar Contracts

Same NAICS industry code

MANAGE AND OPERATE THE NATIONAL RENEWABLE ENERGY LABORATORYThe Department of Energy, through the Golden Field Office, is forecasting a contract to manage and operate the National Renewable Energy Laboratory located in Colorado. This initiative falls under NAICS code 541711 and is currently associated with the incumbent contractor, Alliance for Energy Innovation, LLC. The opportunity is listed as a forecast with a posted date of October 25, 2026. Yolanda Dixon serves as the Small Business Program Manager and primary point of contact for this requirement.

Golden Field Office

POSTED

DEADLINE

Research Subaward / Collaborative Research PartnerThis subcontract establishes a collaborative research partnership to support prime contractors on research projects funded by the National Science Foundation and UK Research and Innovation, specifically under the Arts and Humanities Research Council. The selected partner is responsible for executing specialized research tasks, including data collection and analysis, following project-defined methodologies to solve specific research challenges and support planned outputs. Key deliverables include the provision of research data, detailed analysis reports, and contributions to final publications. To ensure compliance, all work must adhere to the NSF Grant Policy Manual and established UKRI funding norms. The engagement is categorized under NAICS code 541711, focusing on research and experimental development in the natural sciences and engineering.

Arts and Humanities Research Council (AHRC)

POSTED

about 1 month ago

DEADLINE

Research Collaboration and Laboratory AnalysisThe Research Collaboration and Laboratory Analysis subcontract is issued by the National Institute of Food and Agriculture under the Department of Agriculture. This agreement focuses on supporting grant recipients of the USDA-NIFA 1890 Capacity Building Grant Program through the execution of research tasks, data collection, and laboratory analysis. The scope of work includes conducting field trials and laboratory testing to meet specific scientific objectives, with required deliverables consisting of research data sets, technical reports, and peer-reviewed publications. Classified under NAICS code 541711, the opportunity was posted on September 3, 2026, with a response deadline of November 4, 2026. This subcontract is designed to provide essential technical and analytical support to ensure the successful completion of research goals within the specified grant program.

National Institute Of Food And Agriculture

POSTED

about 2 months ago

DEADLINE

Novel In-Situ Binder Chemistry DevelopmentThe NASA SBIR/STTR Program is seeking a subcontractor for the development of a novel in-situ binder chemistry designed for use on the Moon or Mars. The primary objective of this project is to create a binder sourced entirely from lunar or Martian regolith that can cure without the need for external energy input. The scope of work encompasses the initial formulation, lab-scale testing, and subsequent optimization of the chemistry to ensure viability for extraterrestrial construction. This opportunity is designated as a Total Small Business Set-Aside under the SBIR/STTR mandate, specifically for firms with fewer than 500 employees. The work will be performed at the Kennedy Space Center, falling under NAICS code 541711 for research and development in biotechnology. The solicitation was posted on August 20, 2026, as part of NASA's efforts to advance sustainable infrastructure capabilities for deep space exploration.

NASA SBIR/STTR Program

POSTED

DEADLINE

High-Throughput Serology Assay DevelopmentThe contract requires the design, validation, and delivery of a high-throughput serology platform intended to match or surpass the performance of the current hemagglutination inhibition (HAI) assay used for influenza surveillance. The platform must be scalable and robust enough to support large-scale, rapid serological testing, ensuring accurate and consistent data collection for public health monitoring. Development must adhere to stringent performance benchmarks, with a focus on improving throughput, precision, and reproducibility across diverse influenza strains and sample types. This is a subcontract under the Department of Defense’s FA9000 AFGPO program, with performance centered at DWG. The North American Industry Classification System code 541711 indicates it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on June 15, 2026, and the work is expected to advance the DoD’s capability in infectious disease surveillance by replacing aging laboratory methods with a next-generation automated system. While no set-aside or point of contact details are provided, the project’s success is critical to maintaining national-level preparedness for seasonal and pandemic influenza threats.

FA9000 Af Naf Po

POSTED

DEADLINE

Engineering & Scientific Research SupportThe contract entails providing engineering analysis, research and development, and technical support specifically focused on F-15 aircraft systems, encompassing avionics, propulsion, and weapons integration. The work involves activities such as modeling, simulation, and the formulation of test plans to support enhancements and maintenance of these complex systems. Issued by the Department of Defense under the NAICS code 541711, this subcontract titled "Engineering & Scientific Research Support" is designed to advance the technical capabilities and reliability of the F-15 platform. While certain logistical details like the exact place of performance and point of contact are not specified, the contract underscores a commitment to rigorous scientific and engineering efforts to ensure mission readiness and technological superiority for this key military asset.

FA8622 Aflcmc Azs Epass

POSTED

DEADLINE

Technical Research and Analysis (Science & Technology Focus)This contract involves conducting advanced technical research across physical, engineering, and life sciences disciplines to support innovation and technology development within the defense sector. It is a subcontract opportunity issued by the Department of Defense through Washington Headquarters Services, aimed at advancing scientific and technological capabilities that bolster defense-related projects and initiatives. Designated as a Total Small Business Set-Aside under SBA regulations, the contract falls under NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. The work is to be performed in Washington, reflecting a focus on high-impact, cutting-edge research that addresses critical defense challenges. This opportunity emphasizes the Department of Defense's commitment to engaging small businesses in strategic research efforts that drive forward defense technology and innovation.

Washington Headquarters Services

POSTED

DEADLINE

Vehicle Recompete: IGF::OT::IGF ID/IQ PARENT AWARD FOR PHARMACOLOGY AND TOXICOLOGY FOR… — INDEFINITE DELIVERY / INDEFINITE QUANTITY NIHNINDS1601This Indefinite Delivery/Indefinite Quantity parent award supports the Pharmacology and Toxicology for Therapeutics Program under the National Institutes of Health. The vehicle, identified by solicitation NIHNINDS1601, has an ordering period that extends through September 12, 2027. It is currently classified as a full recompete and is associated with two primary awards, HHSN271201600006I and HHSN271201600007I. There are currently 18 active task orders with a total combined value of over 18.7 million dollars. SRI International is the dominant incumbent, holding 15 orders totaling approximately 17.1 million dollars, with significant funding dedicated to continuous rodent and non-rodent pharmacokinetic assessments and GLP toxicology studies. Southern Research Institute holds the remaining three orders, valued at approximately 1.66 million dollars.

National Institutes of Health

POSTED

DEADLINE

Biotechnology and Life Sciences R&DThis subcontract, issued by the Department of Defense's AFRL Headquarters, focuses on biotechnology and life sciences research and development with an emphasis on defense-related applications. The scope involves advancing technologies such as bio-sensing, enhancing human performance, and developing medical countermeasures to support military readiness and resilience. The contract falls under the NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. Although certain logistical details like specific location and points of contact are not provided, the work aims to contribute cutting-edge biotechnological innovations for national defense purposes. The solicitation was posted in January 2026, indicating a current opportunity for entities capable of delivering advanced R&D services in these specialized fields, collaborating closely with the Department of Defense to address evolving defense challenges through scientific and technological efforts.

FA8652 Afrl Hq Afrl/pk

POSTED

DEADLINE

Green Chemistry R&D SupportThe Green Chemistry R&D Support subcontract, issued by the California Department of Toxic Substances Control, focuses on advancing the safety of nail product formulations. The primary objective is to assist manufacturers in researching and developing safer alternatives through the application of green chemistry initiatives, scientific collaboration, and rigorous pilot testing. This initiative falls under NAICS code 541711, indicating a focus on research and development in the physical, engineering, and life sciences. The project was posted on December 23, 2025, and aims to reduce hazardous substances in consumer products through targeted technical support and innovation.

California Toxic Substances Control, Department of

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The objective is to maintain a permanent readiness posture against high-threat influenza and other viruses with pandemic potential. Selected contractors will provide essential services, personnel, and facilities to produce vaccines, antigens, and adjuvants, while generating the necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data for FDA submission to support rapid regulatory decisions. To be eligible, offerors must be capable of producing vaccines against influenza strains with pandemic potential and demonstrate success through a U.S. influenza vaccine license or a submitted Biologics License Application. The government intends to award contracts to four offerors based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology. Evaluation focuses on capabilities, past performance, and price, with a minimum requirement of a High Confidence rating for technical capabilities. The contract structure consists of a 60-month base period and a 60-month option period, with a minimum guarantee of 50,000 dollars. Key requirements include the development of comprehensive manufacturing and business continuity plans, adherence to strict ASPR security and cybersecurity standards, and the use of the Department of Treasury Invoice Processing Platform for quarterly invoicing. Performance is monitored through a BARDA dose tracker, and final acceptance is triggered by the submission of a final report and updated dose tracking data.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

PHI Cybersecurity ImplementationThe PHI Cybersecurity Implementation subcontract, issued by the Department of Health and Human Services under BARDA, focuses on establishing robust cybersecurity frameworks to protect sensitive patient health information for medical device projects. The scope of work includes the deployment of secure cloud infrastructure, encryption protocols, and secure data transmission systems to ensure safe medical device connectivity. The selected provider will deliver a comprehensive secure data management system and a final cybersecurity certification. Strict adherence to regulatory and technical standards is required, specifically HIPAA compliance, NIST SP 800-53, and HITRUST standards. This opportunity falls under NAICS code 541512 and is based in Washington. Interested parties must submit their responses by November 18, 2026.

Computer Systems Design Services

POSTED

DEADLINE

Medical Device Logistics and Surge DistributionThis subcontract for Medical Device Logistics and Surge Distribution supports prime contractors on BARDA medical device projects under the Department of Health and Human Services. The scope of work involves comprehensive warehousing, inventory management, and the rapid distribution of medical devices to hospitals and emergency departments. A critical component of the contract is the management of surge capacity for mass casualty events, utilizing climate-controlled facilities and medical-grade logistics software to ensure efficient delivery to designated care settings. To ensure safety and regulatory adherence, the provider must maintain strict compliance with Good Distribution Practice and HIPAA standards. The project is categorized under NAICS code 493110 and is centered in Washington. Interested parties should note the response deadline of November 18, 2026.

General Warehousing and Storage

POSTED

DEADLINE

Medical-Grade Raw Material SupplyThis subcontract, titled Medical-Grade Raw Material Supply, involves the sourcing, quality testing, and delivery of essential raw materials used in the production of trauma and fracture-management devices. Supporting prime contractors on BARDA medical device projects under the Department of Health and Human Services, the scope of work focuses on providing medical-grade titanium, stainless steel, and specialized polymers. To ensure safety and efficacy, the contractor must provide full material certifications and maintain strict compliance with medical grade purity standards. The project is associated with NAICS code 325211 and is designated for performance in Washington, with a response deadline set for November 18, 2026.

Plastics Material and Resin Manufacturing

POSTED

DEADLINE

Specialized Medical Component FabricationThis subcontract for Specialized Medical Component Fabrication involves the production of precision components for medical devices focused on trauma care and fracture stabilization. Working under prime contractors for BARDA projects within the Department of Health and Human Services, the selected provider will utilize precision CNC machining and molding to fabricate hardware from biocompatible polymers and medical-grade alloys. The contract requires strict adherence to FDA regulatory compliance and ISO 13485 certification to ensure the quality of the finished medical device components. Performance will take place in Washington, with a response deadline set for November 18, 2026.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

DEADLINE

Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection

Solicitation # BARDA-FY27-10192026

The Center for Biomedical Advanced Research and Development Authority (BARDA) has issued Sources Sought Notice BARDA-FY27-10192026 to identify innovative medical countermeasure technologies for the rapid triage of musculoskeletal injuries, such as fractures and soft tissue injuries of extremities. This request for information is intended for planning and market research purposes to assess commercially available or nearing-commercial technologies that utilize Super Intelligence (SI) and machine learning for automated ultrasound-based fracture detection. The goal is to find standalone, point-of-care devices that can operate in emergency departments, urgent care centers, and austere field settings without relying on traditional imaging infrastructure like X-ray or CT scans. The desired technology must feature automated volumetric capture, 3D-rotatable modeling, and SI-enabled image processing that outperforms human imaging experts and has undergone FDA 510k clearance processes. BARDA is interested in ruggedized, portable units with sufficient battery life for disaster response, interoperability with electronic health record systems, and minimal training requirements for non-specialist operators. Potential acquisition strategies being explored include direct purchases, leases, or vendor-managed inventory arrangements. Interested small businesses and other than small business concerns under NAICS code 334510 must submit their capabilities statements by 1:00 p.m. Eastern Time on November 18, 2026. Submissions must include separate Technical and Business Representation sections, each limited to 10 pages in 12-point Times New Roman font, and be emailed to Justin Moore and Richard Hall. Responses should detail the company's manufacturing capabilities within the United States, regulatory maturity, supply chain resilience, and cybersecurity standards for handling sensitive patient health information.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

DEADLINE

Vaccine Lot Production (Research, Investigational, and Commercial)This subcontract involves the production of influenza vaccine antigens and vaccines across research, investigational, and commercial bulk scales to support prime contractors on BARDA pandemic preparedness projects. The work is performed within cGMP compliant facilities to ensure all investigational and commercial lots meet strict regulatory alignment and quality standards. Managed by the Department of Health and Human Services under the Barda agency, the contract focuses on delivering bulk vaccine lots across three distinct production scales. The opportunity is categorized under NAICS code 325412, with a response deadline set for October 30, 2026, and performance based in Washington.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 22 hours

cGMP Vaccine Seed Lot ManufacturingThis subcontract for cGMP Vaccine Seed Lot Manufacturing involves the production of yield-optimized Master Virus Seed, Working Virus Seed lots, or bacterial cell banks to support BARDA pandemic preparedness projects. The work is performed for prime contractors using qualified CVV reference strains within cGMP certified facilities that align with FDA-licensed vaccines or submitted BLAs. All seeds are characterized according to qualified internal standard operating procedures to ensure the delivery of certified lots. Managed by the Department of Health and Human Services under Barda, the contract falls under NAICS code 325412. The performance location is based in Washington, DC, with a response deadline of October 30, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 22 hours

Candidate Vaccine Virus (CVV) Development & CharacterizationThis subcontract, titled Candidate Vaccine Virus Development and Characterization, supports BARDA pandemic preparedness projects by preparing and characterizing both non-GLP and GLP influenza Candidate Vaccine Viruses. The scope of work includes performing HA/NA sequencing, genetic stability testing, ferret pathogenicity, two-way antigenicity, HA titer, sterility, and exclusivity. Additionally, the contractor is responsible for conducting plaque assays and chicken embryo lethality for HPAI strains within a BSL-2 environment, culminating in the delivery of final reports and Certificates of Analysis or Compliance. Managed by the Department of Health and Human Services under the Barda - Aspr agency, the project is categorized under NAICS code 541714. The performance location is based in Washington, DC. The solicitation was posted on August 17, 2026, with a response deadline set for October 30, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in about 22 hours

Specialized Material Supply (Vials, Stoppers, Seals)This subcontract for Specialized Material Supply focuses on providing critical medical-grade components, including vials, stoppers, seals, and crimps, to support prime contractors on BARDA pandemic preparedness projects. The scope of work requires the delivery of physical inventory and the provision of comprehensive supply chain narratives that detail the country of origin and tariff exposure for all containment and closure materials. Managed by the Department of Health and Human Services under the agency Barda - Aspr / Daappo / Barda Dcma, the contract is categorized under NAICS code 326199. The place of performance is located in Washington, DC, with a response deadline set for October 30, 2026.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

in about 22 hours

Labeling, Packaging, and Cold Chain StorageThis subcontract, managed by the Department of Health and Human Services under BARDA, focuses on providing essential labeling, packaging, and specialized stability storage for bulk and final vaccine products. The scope of work involves supporting prime contractors on pandemic preparedness projects by managing cold chain logistics and stability monitoring for commercial scale bulk antigens, final containers, and bulk adjuvants. The contractor is responsible for the delivery of packaged products and the provision of detailed stability reports. This opportunity is categorized under NAICS code 493110 and is based in Washington, DC. The response deadline for this requirement is October 30, 2026.

General Warehousing and Storage

POSTED

DEADLINE

in about 22 hours

Formulation, Filling, and Finishing ServicesThis subcontract for Formulation, Filling, and Finishing Services supports BARDA pandemic preparedness projects by providing final formulation and filling of antigens, adjuvants, or co-formulated products into final containers. The work is performed under cGMP compliant processes within sterile filling environments to ensure the delivery of high-quality filled vials and containers for prime contractors. The opportunity is managed by the Department of Health and Human Services under the Barda - Aspr / Daappo / Barda Dcma agency and is categorized under NAICS code 325412. The project is based in Washington, DC, with a response deadline of October 30, 2026.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

in about 22 hours

Earlier notices in this NAICS code

Posted before this notice, open and closed

Custom Chemical Synthesis and Purification

National Institute Of Health Niehs

POSTED

almost 2 years ago

CLOSED

almost 2 years ago

Terrain Data Analysis & Software Tools

W6QK Acc-Apg Director

POSTED

about 6 years ago

CLOSED

about 6 years ago

Drug Countermeasures against Bacterial Biowarfare Agents

Solicitation # W911QY-18-S-0001

W6QK Acc-Apg Natick

POSTED

about 9 years ago

CLOSED

almost 9 years ago

Solicitation # 17-100-SOL-00013

POSTED

about 9 years ago

CLOSED

about 9 years ago

Animal Husbandry, Animal Care and Technical Support Services

Solicitation # FDA-SOL-1153590

POSTED

about 9 years ago

CLOSED

about 9 years ago

Intent to Annouce - RPP 18-01 of MCDC OTA

Solicitation # W15QKN18Z0B9X

POSTED

about 9 years ago

DEADLINE

65--Equipment Microperfusion System Twin Channel - Iowa City VA

Solicitation # VA26317Q1151

POSTED

about 9 years ago

CLOSED

about 9 years ago

BioGears Follow On - BA160204

Solicitation # W81XWH-16-R-BAA1

POSTED

about 9 years ago

CLOSED

about 9 years ago

Division of Microbiology and Infectious Diseases (DMID) Clinical Materials Services

Solicitation # NIAID-DMID-NIHAI2016065

POSTED

about 9 years ago

CLOSED

about 9 years ago

Purchase of Ovarian Cancer Tissue Blocks from the Nurses Health Study

Solicitation # N02CO72732-95

POSTED

about 9 years ago

CLOSED

about 9 years ago

Spectra T120 Tape Library

Solicitation # W81XWH-17-T-0453

POSTED

about 9 years ago

CLOSED

about 9 years ago

Quantitative Targeted Metabolomics Assays and Analysis

Solicitation # HHS-NIH-NIDA-SSSA-NOI-2017-661

POSTED

about 9 years ago

CLOSED

about 9 years ago

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS